-
摘要: 减瘤手术在治疗某些转移性肿瘤中的效果已经得到证实。在我国,相当一部分新发现的前列腺癌患者已经出现骨转移,对于转移性前列腺癌(mPCa)患者,减瘤手术是否有效,国内外也做了大量研究,本文就mPCa减瘤手术的研究进展作一综述。Abstract: The benefits of cytoreductive surgery for some metastatic malignancies have been confirmed. In China, a large number of newly diagnosed prostate cancers are found accompanied with bone metastasis. In recent years, many studies have been performed to confirm if cytoreductive is effective for prostate cancer with bone metastasis. Advancement in cytoreductive surgery for metastatic prostate cancer is reviewed.
-
-
[1] Flanigan RC,Salmon SE,Blumenstein BA,et al.Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer[J].N Engl J Med,2001,345(23):1655-1659.
[2] Garcia-Perdomo HA,Zapata-Copete JA,Castillo-Cobaleda DF.Role of cytoreductive nephrectomy in the targeted therapy era:A systematic review and meta-analysis[J].Investig Clin Urol,2018,59(1):2-9.
[3] Elias D,Lefevre JH,Chevalier J,et al.Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin[J].J Clin Oncol,2009,27(5):681-685.
[4] Esquivel J,Sticca R,Sugarbaker P,et al.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin:a consensus statement.Society of Surgical Oncology[J].Ann Surg Oncol,2007,14(1):128-133.
[5] Bristow RE,Tomacruz RS,Armstrong DK,et al.Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis[J].J Clin Oncol,2002,20(5):1248-1259.
[6] Miyamoto DT,Sequist LV,Lee RJ.Circulating tumour cells-monitoring treatment response in prostate cancer[J].Nat Rev Clin Oncol,2014,11(7):401-412.
[7] Swanson G,Thompson I,Basler J,et al.Metastatic prostate cancer-does treatment of the primary tumor matter?[J].J Urol,2006,176(4 Pt 1):1292-1298.
[8] 王艳龙,杜浩,任宇,等.减瘤性前列腺切除术治疗前列腺癌骨转移患者的研究进展[J].中华泌尿外科杂志,2017,38(1):72-74.
[9] 赵炎,梁杰,林英立,等.根治性前列腺切除术在盆腔淋巴结受侵及转移性前列腺癌中的应用及现状[J].临床泌尿外科杂志,2019,34(12):1009-1012.
[10] Mostaghel EA,Page ST,Lin DW,et al.Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression:therapeutic implications for castration-resistant prostate cancer[J].Cancer Res,2007,67(10):5033-5041.
[11] Negri-Cesi P,Motta M.Androgen metabolism in the human prostatic cancer cell line LNCaP[J].J Steroid Biochem Mol Biol,1994,51(1-2):89-96.
[12] Faiena I,Singer EA,Pumill C,et al.Cytoreductive prostatectomy:evidence in support of a new surgical paradigm(Review)[J].Int J Oncol,2014,45(6):2193-2198.
[13] 王野,高旭,杨庆,等.前列腺癌骨转移发生机制的研究进展[J].中华泌尿外科杂志,2015,36(9):715-717.
[14] Ojo D,Lin X,Wong N,et al.Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer[J].Cancers(Basel),2015,7(4):2290-2308.
[15] Cifuentes FF,Valenzuela RH,Contreras HR,et al.Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer[J].Oncol Rep,2015,34(6):2837-2844.
[16] Poelaert F,Verbaeys C,Rappe B,et al.Cytoreductive Prostatectomy for Metastatic Prostate Cancer:First Lessons Learned From the Multicentric Prospective Local Treatment of Metastatic Prostate Cancer(LoMP)Trial[J].Urology,2017,106:146-152.
[17] Wang Y,Qin Z,Wang Y,et al.The role of radical prostatectomy for the treatment of metastatic prostate cancer:a systematic review and meta-analysis[J].Biosci Rep,2018,38(1):BSR20171379.
[18] Tilki D,Pompe RS,Bandini M,et al.Local treatment for metastatic prostate cancer:A systematic review[J].Int J Urol,2018,25(5):390-403.
[19] Culp SH,Schellhammer PF,Williams MB.Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor?A SEER-based study[J].Eur Urol,2014,65(6):1058-1066.
[20] Fossati N,Trinh QD,Sammon J,et al.Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer:a SEER-based study[J].Eur Urol,2015,67(1):3-6.
[21] Leyh-Bannurah SR,Gazdovich S,Budaus L,et al.Local Therapy Improves Survival in Metastatic Prostate Cancer[J].Eur Urol,2017,72(1):118-124.
[22] Pompe RS,Tilki D,Preisser F,et al.Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages[J].Prostatem2018,78(10):753-757.
[23] Rusthoven CG,Jones BL,Flaig TW,et al.Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer[J].J Clin Oncol,2016,34(24):2835-2842.
[24] Loppenberg B,Dalela D,Karabon P,et al.The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis:A National Cancer Data Base Analysis[J].Eur Urol,2017,72(1):14-19.
[25] Sooriakumaran P,Nyberg T,Akre O,et al.Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy[J].Eur Urol,2017,72(3):345-351.
[26] Steuber T,Berg KD,Roder MA,et al.Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis?Results from a Prospective Case-Control Study[J].Eur Urol Focus,2017,3(6):646-649.
[27] Qin XJ,Ma CG,Ye DW,et al.Tumor cytoreduction results in better response to androgen ablation——a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer[J].Urol Oncol,2012,30(2):145-149.
[28] 李涛,魏乔红,傅崇德,等.经尿道前列腺电切联合内分泌治疗晚期前列腺癌膀胱出口梗阻疗效的荟萃分析[J].中华腔镜泌尿外科杂志(电子版),2017,11(5):295-301.
[29] Nazario J,Hernandez J,Tam AL.Thermal ablation of painful bone metastases[J].Tech Vasc Interv Radiol,2011,14(3):150-159.
[30] Sabharwal T,Katsanos K,Buy X,et al.Image-guided ablation therapy of bone tumors[J].Semin Ultrasound CT MR,2009,30(2):78-90.
[31] Lee S R,Oh JY,Kim SH.Gamma Knife radiosurgery for cystic brain metastases[J].Br J Neurosurg,2016,30(1):43-48.
[32] Wang H,Qi S,Dou C,et al.Gamma Knife radiosurgery combined with stereotactic aspiration as an effective treatment method for large cystic brain metastases[J].Oncol Lett,2016,12(1):343-347.
[33] Parikh RR,Byun J,Goyal S,et al.Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer[J].Prostate,2017,77(6):559-572.
[34] 许传亮,常易凡,孙颖浩.寡转移前列腺癌手术治疗的相关问题[J].临床泌尿外科杂志,2017,32(09):653-657.
[35] Heidenreich A,Pfister D,Porres D.Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases:results of a feasibility and case-control study[J].J Urol,2015,193(3):832-838.
[36] Kim DK,Parihar JS,Kwon YS,et al.Risk of complications and urinary incontinence following cytoreductive prostatectomy:a multi-institutional study[J].Asian J Androl,2018,20(1):9-14.
[37] Sooriakumaran P,Karnes J,Stief C,et al.A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation[J].Eur Urol,2016,69(5):788-794.
[38] Tewari A,Sooriakumaran P,Bloch DA,et al.Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer:a systematic review and meta-analysis comparing retropubic,laparoscopic,and robotic prostatectomy[J].Eur Urol,2012,62(1):1-15.
[39] Musch M,Klevecka V,Roggenbuck U,et al.Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006[J].J Urol,2008,179(3):923-928,928-929.
[40] Preisser F,Mazzone E,Nazzani S,et al.Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer[J].Eur Urol,2018,74(6):693-696.
-
计量
- 文章访问数: 535
- PDF下载数: 322
- 施引文献: 0
下载: